A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is the most common malignancy of liver cancer. However, treatment of HCC is still severely limited due to limitation of drug therapy. We aimed to screen more possible target genes and candidate drugs for HCC, exploring the possibility of drug treatments...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Meng, Shong, Koeun, Li, Xiangyu, Ashraf, Sajda, Shi, Mengnan, Kim, Woonghee, Nielsen, Jens, Turkez, Hasan, Shoaie, Saeed, Uhlen, Mathias, Zhang, Cheng, Mardinoglu, Adil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946504/
https://www.ncbi.nlm.nih.gov/pubmed/35326724
http://dx.doi.org/10.3390/cancers14061573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946504/
https://www.ncbi.nlm.nih.gov/pubmed/35326724
http://dx.doi.org/10.3390/cancers14061573

Ejemplares similares